Compounds > bucladesine

bucladesine and flufenamic acid

bucladesine has been researched along with flufenamic acid in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19904 (57.14)18.7374
1990's1 (14.29)18.2507
2000's0 (0.00)29.6817
2010's2 (28.57)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL1
Chobsieng, P; Koch, Y; Naor, Z; Zor, U1
Beil, W; Greite, C; Sewing, KF1
Baldwin, DM; Bourne, GA2
Chinea, G; Oronsky, AL; Perper, RJ; Sanda, M1

Other Studies

7 other study(ies) available for bucladesine and flufenamic acid

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
    PloS one, 2016, Volume: 11, Issue:10

    Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat

2016
Pituitary cyclic AMP production and mechanism of luteinizing hormone release.
    FEBS letters, 1975, Oct-15, Volume: 58, Issue:1

    Topics: Animals; Bucladesine; Cyclic AMP; Flufenamic Acid; Gonadotropin-Releasing Hormone; Luteinizing Hormone; Male; Pituitary Gland; Pituitary Gland, Anterior; Prostaglandins E; Rats

1975
Interaction of the non-steroidal anti-inflammatory drug flufenamic acid with gastric acid secretion and H+/K(+)-ATPase.
    Clinical and experimental pharmacology & physiology, 1992, Volume: 19, Issue:8

    Topics: Adenosine Triphosphatases; Animals; Bucladesine; Cell Membrane; Flufenamic Acid; Gastric Acid; Guinea Pigs; H(+)-K(+)-Exchanging ATPase; In Vitro Techniques; Parietal Cells, Gastric; Potassium Chloride; Protons

1992
Evidence for cAMP as a mediator of gonadotropin secretion from female pituitaries.
    The American journal of physiology, 1987, Volume: 253, Issue:3 Pt 1

    Topics: Adenosine Monophosphate; Animals; Bucladesine; Butyrates; Butyric Acid; Cyclic AMP; Cycloheximide; Dopamine; Female; Flufenamic Acid; Gonadotropins, Pituitary; Osmolar Concentration; Pituitary Hormone-Releasing Hormones; Rats; Rats, Inbred Strains; Sex Characteristics

1987
Evidence for cAMP as a mediator of gonadotropin secretion from male pituitaries.
    The American journal of physiology, 1987, Volume: 253, Issue:3 Pt 1

    Topics: Animals; Bucladesine; Cyclic AMP; Cycloheximide; Flufenamic Acid; Gonadotropins, Pituitary; Growth Hormone-Releasing Hormone; Male; Rats; Rats, Inbred Strains; Sex Characteristics

1987
Leukocyte chemotaxis in vivo. II. Analysis of the selective inhibition of neutrophil or mononuclear cell accumulation.
    The Journal of laboratory and clinical medicine, 1974, Volume: 84, Issue:3

    Topics: Animals; Bucladesine; Carrageenan; Chemotaxis; Chloroquine; Chlorpromazine; Chromium Radioisotopes; Clonidine; Colchicine; Cyclophosphamide; Female; Flufenamic Acid; Indomethacin; Inflammation; Leukocyte Transfusion; Leukocytes; Methylprednisolone; Monocytes; Neutrophils; Phenylbutazone; Rats; Transplantation, Homologous; Venoms; Vinblastine

1974